Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-11-16
2010-02-23
Henley, III, Raymond J (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S255010, C514S315000, C514S381000, C514S391000, C544S106000, C544S381000, C544S391000
Reexamination Certificate
active
07666865
ABSTRACT:
Compounds of the formulawherein m is 0, 1 or 2;wherein when m is 0, Z is O, when m is 1, Z is N, and when m is 2, Z is C;Y is H, OH, NH2, or an organic moiety of 1-20C, optionally additionally containing 1-8 heteroatoms selected from the group consisting of N, P, O, S and halo;each l1and l2is independently 0-5;l3is 0 or 1;each of R1, R2and R3is independently alkyl (1-6C), aryl (6-10C) or arylalkyl (7-16C) optionally containing 1-4 heteroatoms selected from the group consisting of halo, N, P, O, and S or each of R1and R2may independently be halo, COOR, CONR2, CF3, CN or NO2, wherein R is H or lower alkyl (1-4C) or alkyl (1-6C);n is 0 or 1;X is a linker;with the proviso that Y is not a tropolone, a coumarin, or an antioxidant containing an aromatic group and with the further proviso that if l3is 0, and either l1and l2is 0 or 1 and if R1and/or R2represent F in the para position, Z cannot be C or N; andare useful to treat pain. Libraries of these compounds can also be used to identify antagonists for other targets.
REFERENCES:
patent: 3288795 (1966-11-01), Irikura et al.
patent: 4188485 (1980-02-01), Kukla
patent: 4918073 (1990-04-01), Ruger et al.
patent: 5386025 (1995-01-01), Jay et al.
patent: 5428038 (1995-06-01), Chatterjee et al.
patent: 5623051 (1997-04-01), Catterall et al.
patent: 5646149 (1997-07-01), Hellberg et al.
patent: 5703071 (1997-12-01), Itoh et al.
patent: 6011035 (2000-01-01), Snutch et al.
patent: 6294533 (2001-09-01), Snutch et al.
patent: 6387897 (2002-05-01), Snutch
patent: 6617322 (2003-09-01), Snutch
patent: 7186726 (2007-03-01), Snutch et al.
patent: 0187524 (1986-07-01), None
patent: 0458387 (1991-11-01), None
patent: 504202 (1983-01-01), None
patent: 514167 (1983-04-01), None
patent: 1513883 (1978-06-01), None
patent: WO-99/15129 (1999-04-01), None
patent: WO-99/25686 (1999-05-01), None
Galizzi, J-P. et al.Proc Natl Acad Sci USA(1986) 83:7513-7517.
Gould, R.J. et al.Proc Natl Acad Sci USA(1983) 80:5122-5125.
Grantham, C.J. et al.Brit J Pharmacol(1994) 111:438-488.
Ito, C. et al.Eur J Pharmacol(1994) 257:203-210.
King, V.F. et al.J Biol Chem(1989) 264:5633-5641.
“Lomerizine Kanebo KK” published inCurrent Opinion in CPNS Investigational Drugs(1999) 1(1):116-125.
Bourinet et al., Nature Neuroscience (1999) 2:407-415.
Cohan et al., Annals of the New York Academy of Sciences (1991) 635:397-399.
Cribbs et al., Circulation Research (1998) 83:103-109.
Database WPI Week 9711, Derwent Publications Ltd. London, GB; Abstract JP09 003067, XP002133055 (Hisamitsu Pharm Co Ltd.) Jan. 7, 1997.
De Waard et al., Ion Channels (Narahashi, ed., Plenum Press, NY, 1997) 4:41-87.
Dhainaut et al., J Med Chem (1992) 35:2481-2496.
Dooley, Current Opinion in CPNS Investigational Drugs (1999) 1(1):116-125.
Dunlap et al., Trends Neurosci (1995) 18:89-98.
Estep et al., J Med Chem (1995) 38:2582-2595.
Galizzi et al., PNAS USA (1986) 83:7513-7517.
Glamkowski et al., J Med Chem (1977) 20(11):1485-1489.
Gould et al., PNAS (1983) 80:5122-5125.
Grantham et al., Brit J Pharmacol (1994) 111:438-488.
Ito et al., Eur J Pharmacol (1994) 257:203-210.
King et al., J Biol Chem (1989) 264:5633-5641.
Lee et al., Journal of Neuroscience (1999) 19:1912-1921.
Lehmann et al., Arch Pharm (1988) 321:807-812.
McCleskey et al., Curr Topics Membr (1991) 39:295-326.
Miyano et al., Chem Pharm Bull (1990) 38(6):1570-1574.
Ohtaka et al., Chem Pharm Bull (1987) 35(8):3270-3275.
Ohtaka et al., Chem Pharm Bull (1987) 35(10):4117-4123.
Perez-Reyes et al., Nature (1998) 391:896-900.
Prasad et al., J Med Chem (1968) 11(6):1144-1150.
Sather et al., Neuron (1993) 11:291-303.
Stea et al., Handbook of Receptors and Channels (North, ed., CRC Press 1995) 113-151.
Stea et al., PNAS USA (1994) 91:10576-10580.
Tytgat et al., Brain Research (1991) 549:112-117.
Uneyama et al., Calcium Ion Modulator, Sel Pap Satell Symp (1988) 13-23.
Vadodaria et al., J Med Chem (1969) 12:860-865.
Zikolova et al., Tr Nauchnoizsled Khim—Farm Inst (1984) 14:23-28.
Zikolova et al., Tr Nauchnoizsled Khim—Farm Inst (1972) 8:59-67.
Snutch Terrance P.
Zamponi Gerald W.
Henley, III Raymond J
Morrison & Foerster / LLP
Neuromed Pharmaceuticals Ltd.
LandOfFree
Calcium channel blockers does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Calcium channel blockers, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Calcium channel blockers will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4212575